SRx Health Solutions Inc.
US ˙ NYSEAM ˙ US08771Y2046
DENNA SYMBOL ÄR INTE LÄNGRE AKTIV

SecurityBTTR / SRx Health Solutions Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership85,742 shares
Latest Disclosed Value $ 11,061
UBS Group AG reports 99.24% increase in ownership of BTTR / SRx Health Solutions Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 85,742 shares of SRx Health Solutions Inc. (US:BTTR) valued at $11,061 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 43,035 shares of SRx Health Solutions Inc.. This represents a change in shares of 99.24% during the quarter. The current value of the position is $181,773 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F SRX HEALTH SOLUTIONS COM NEW 08771Y402 85,742 42,707 99.24 11 22.22 0.0000
2026-01-29 2025-12-31 13F SRX HEALTH SOLUTIONS COM NEW 08771Y402 43,035 42,639 10,767.42 10 0.0000
2025-11-13 2025-09-30 13F SRX HEALTH SOLUTIONS COM NEW 08771Y402 396 10 2.59 0 0.0000
2025-08-14 2025-06-30 13F SRX HEALTH SOLUTIONS COM NEW 08771Y402 386 -5,883 -93.84 0 -100.00 0.0000
2025-05-13 2025-03-31 13F BETTER CHOICE COM NEW 08771Y402 6,269 -9 -0.14 11 -28.57 0.0000
2025-02-14 2024-12-31 13F BETTER CHOICE COM NEW 08771Y402 6,278 6,278 15 0.0000
2024-11-14 2024-09-30 13F BETTER CHOICE COM NEW 08771Y402 0 -1,157 -100.00 0 -100.00
2024-08-14 2024-06-30 13F BETTER CHOICE COM NEW 08771Y402 1,157 565 95.44 5 33.33 0.0000
2024-05-13 2024-03-31 13F BETTER CHOICE COM NEW 08771Y402 592 592 4 0.0000
2024-02-09 2023-12-31 13F BETTER CHOICE COM 08771Y303 1,000 1,000 0 0.0000
2023-05-12 2023-03-31 13F BETTER CHOICE COM 08771Y303 0 -22,211 -100.00 0 -100.00
2023-02-08 2022-12-31 13F BETTER CHOICE COM 08771Y303 22,211 14,926 204.89 12 83.33 0.0000
2022-11-10 2022-09-30 13F BETTER CHOICE COM 08771Y303 7,285 7,285 6 0.0000
2022-05-16 2022-03-31 13F BETTER CHOICE COM 08771Y303 0 -3,040 -100.00 0 -100.00
2022-02-14 2021-12-31 13F BETTER CHOICE COM 08771Y303 3,040 3,040 10 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.